发明名称 |
Means and methods for treatment evaluation |
摘要 |
Disclosed is a method for determining whether a treatment is effective in changing a status of a certain set of target cells in an individual comprising determining whether a sample, other than a hemopoietic cell, from said individual comprises an expression product of at least one marker gene, wherein said marker gene comprises Siglec 1. (62) Divided Out of 526924
|
申请公布号 |
NZ537458(A) |
申请公布日期 |
2007.02.23 |
申请号 |
NZ20020537458 |
申请日期 |
2002.01.23 |
申请人 |
PRIMAGEN HOLDING B |
发明人 |
VAN DER KUYL, ANTOINETTE CORNELIA;CORNELISSEN, MARION |
分类号 |
G01N33/50;A61K45/00;A61P35/00;C12N15/09;C12Q1/68;G01N33/53;G01N33/566;G01N33/574;(IPC1-7):C12Q1/68 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|